Infections Deaths in the PLATO Trial

Background Cardiovascular benefits of aggressive dual antiplatelet therapy may be associated with extra risks including bleeding, cancer, and infections discovered first for prasugrel in the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel (TRITON)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Victor Serebruany, Jean-Francois Tanguay
Formato: article
Lenguaje:EN
Publicado: Georg Thieme Verlag KG 2021
Materias:
Acceso en línea:https://doaj.org/article/21f0efbfbda84e639dc973214dd37e3d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!